Medical DeviceNews

AliveCor’s KardiaMobile to alert people experiencing irregular heart rhythm symptoms

KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales

AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced that the National Institute for Health and Care Excellence (NICE) has issued Medical Technologies Guidance (MTG) recommending KardiaMobile as an option for detecting atrial fibrillation (AF) for people with suspected paroxysmal AF, who present with symptoms such as palpitations and are referred for ambulatory ECG monitoring by a clinician. KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales.

THIS CAN BE YOUR ADVERTISEMENT

KardiaMobile would be prescribed by a healthcare professional for people experiencing arrhythmia (irregular heart rhythm) symptoms more than 24 hours apart. The instructions for use state that all interpretations of ECG recordings are reviewed by a healthcare professional and used to support clinical decision making.

“AF diagnosis rates across the UK pre-pandemic were already too low. With difficulties in accessing in-person care and increased waiting times, concern is that diagnosis rates have fallen further, leaving thousands of people at risk of life-threatening cardiovascular complications, such as an AF-related stroke” said Professor Matt Reed, RCEM Professor, Consultant and NRS Fellow in Emergency Medicine, NHS Lothian.

NICE’s recommendation of KardiaMobile as a clinically and cost-effective medical technology is supported by evidence from 27 different studies, including five randomised controlled trials. Data submitted to NICE, showed KardiaMobile was five times more efficacious at detecting heart rhythm problems than standard tests alone, with greater usability. NICE’s MTG evaluates new, innovative medical devices and diagnostics. It assesses medical technologies that deliver treatment, give greater independence to patients and detect or monitor medical conditions.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close